Waverton Investment Management Ltd Has $81.58 Million Holdings in GE HealthCare Technologies Inc. $GEHC

Waverton Investment Management Ltd raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.8% during the third quarter, HoldingsChannel.com reports. The fund owned 1,086,668 shares of the company’s stock after purchasing an additional 29,897 shares during the period. GE HealthCare Technologies makes up about 1.0% of Waverton Investment Management Ltd’s holdings, making the stock its 24th biggest holding. Waverton Investment Management Ltd’s holdings in GE HealthCare Technologies were worth $81,582,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of GE HealthCare Technologies by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock valued at $3,859,622,000 after purchasing an additional 703,903 shares in the last quarter. Dodge & Cox lifted its stake in GE HealthCare Technologies by 42.1% in the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after purchasing an additional 6,982,441 shares during the last quarter. State Street Corp boosted its position in GE HealthCare Technologies by 1.9% in the second quarter. State Street Corp now owns 19,660,742 shares of the company’s stock valued at $1,456,271,000 after buying an additional 372,755 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of GE HealthCare Technologies by 2.0% during the second quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock worth $881,060,000 after buying an additional 231,302 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of GE HealthCare Technologies during the second quarter worth $468,120,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.4%

Shares of GEHC stock opened at $84.27 on Monday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $90.26. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The stock has a 50 day simple moving average of $82.38 and a two-hundred day simple moving average of $78.46. The company has a market cap of $38.41 billion, a P/E ratio of 18.48, a PEG ratio of 1.85 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.07%.

Analysts Set New Price Targets

GEHC has been the topic of a number of recent research reports. BTIG Research lifted their price target on GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a research note on Wednesday, February 4th. Morgan Stanley lifted their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 4th. Evercore upped their price target on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. The Goldman Sachs Group reissued a “buy” rating and issued a $98.00 price objective on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Finally, Citigroup raised their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $92.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.